Roles of Medicinal Plants and Constituents in Gynecological Cancer Therapy: Current Literature and Future Directions
-
Published:2020-08-17
Issue:20
Volume:20
Page:1772-1790
-
ISSN:1568-0266
-
Container-title:Current Topics in Medicinal Chemistry
-
language:en
-
Short-container-title:CTMC
Author:
Akkol Esra Küpeli1ORCID, Dereli Fatma Tuğçe Gürağaç1ORCID, Sobarzo-Sánchez Eduardo2ORCID, Khan Haroon3ORCID
Affiliation:
1. Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Etiler 06330, Ankara, Turkey 2. Instituto de Investigacion e Innovacion en Salud, Facultad de Ciencias de la Salud, Universidad Central de Chile, 8330507 Santiago, Chile 3. Department of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan
Abstract
:
Gynecologic cancers, including cervical, primary peritoneal, ovarian, uterine/endometrial,
vaginal and vulvar cancers and gestational trophoblastic disease, are characterized by abnormal cell
proliferation in female reproductive cells. Due to the variable pathology of these cancers and the lack
of appropriate screening tests in developing countries, cancer diagnosis can be reported in advanced
stages in most women and this situation adversely affects prognosis and clinical outcomes of illness.
For this reason, many researchers in the field of gynecological oncology have carried out many studies.
:
The treatment of various gynecological problems, which cause physical, biological and psychosocial
conditions such as fear, shame, blame and anger, has been important throughout the history. Treatment
with herbs has become popular nowadays due to the serious side effects of the synthetic drugs used in
treatment and the medical and economical problems caused by them. Many scientists have identified
various active drug substances through in vivo and in vitro biological activity studies on medicinal
plants from the past to the present. While the intrinsic complexity of natural product-based drug discoveries
requires highly integrated interdisciplinary approaches, scientific and technological advances
and research trends clearly show that natural products will be among the most important new drug
sources in the future.
:
In this review, an overview of the studies conducted for the discovery of multitargeted drug molecules
in the rational treatment of gynecological cancers is presented.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine
Reference206 articles.
1. W.H.O. (WHO) . The World Health Organization’s fight against cancer: Strategies that prevent, cure and care. Available from: https://www.who.int/can cer/publications/fight_against_cancer/en/ (Accessed Nov 12,2019) 2. Boyle,P.; Levin, B. World cancer report international agency for research on cancer ; IARC: Geneva. 2008,1-6 3. Giammarile,F.; Bozkurt, M.F.; Cibula,D.; Pahisa,J.; Oyen, W.J.; Paredes,P.; Olmos, R.V.; Sicart, S.V. The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers. Eur, J. Nucl. Med. Mol. Imaging. 2014,41(7),1463-1477. http://dx.doi.org/10.1007/s00259-014-2732-8 PMID: 24609929 4. Mais,V.; Peiretti,M.; Gargiulo,T.; Parodo,G.; Cirronis, M.G.; Melis, G.B. Intraoperative sentinel lymph node detection by vital dye through laparoscopy or laparotomy in early endometrial cancer, J. Surg. Oncol. 2010,101(5),408-412. http://dx.doi.org/10.1002/jso.21496 PMID: 20119976 5. Van der Zee, A.G.; Oonk, M.H.; De Hullu, J.A.; Ansink, A.C.; Vergote,I.; Verheijen, R.H.; Maggioni,A.; Gaarenstroom, K.N.; Baldwin, P.J.; Van Dorst, E.B.; Van-der Velden,J.; Hermans, R.H.; van der Putten,H.; Drouin,P.; Schneider,A.; Sluiter, W.J. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer, J. Clin. Oncol. 2008,26(6),884-889. http://dx.doi.org/10.1200/JCO.2007.14.0566 PMID: 18281661
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|